##plugins.themes.academic_pro.article.main##

Abstract

The aim of this study is to investigate whether serum concentrations of MBL correlate with the incidence of preterm birth and low birth weight in a cohort of women with signs of threatened preterm birth

Keywords

Mannose-Binding Lectin Preterm labor Lower Birth Weight

##plugins.themes.academic_pro.article.details##

How to Cite
Pinar Maher Khalifa, & Zuhud M. Mustafa. (2022). Correlation Between Maternal Serum Concentrations of Mannose-Binding Lectin and The Risk of Shorter Duration of Pregnancy and Lower Birth Weight. Texas Journal of Medical Science, 7, 33–40. https://doi.org/10.62480/tjms.2022.vol7.pp33-40

References

  1. Cardozo L, Staskin D. Textbook of Female Urology and Urogynecology, -Two-Volume Set. CRC Press; 2017 Jan 6.
  2. Marzano D. The History of Simulation in Obstetrics and Gynecology. InComprehensive Healthcare Simulation: Obstetrics and Gynecology 2019 (pp. 3-9). Springer, Cham.
  3. Petch S, DeMaio A, Daly S. Prediction of recurrent preterm delivery in asymptomatic women-an anxiety reducing measure?. European Journal of Obstetrics & Gynecology and Reproductive Biology: X. 2019 Jun 7.
  4. Sepulveda-Martinez A, Diaz F, Muñoz H, Valdés E, Parra-Cordero M. Second-trimester anterior cervical angle in a low-risk population as a marker for spontaneous preterm delivery. Fetal diagnosis and therapy. 2017;41(3):220-5.
  5. Temu TB, Masenga G, Obure J, Mosha D, Mahande MJ. Maternal and obstetric risk factors associated with preterm delivery at a referral hospital in northern-eastern Tanzania. Asian Pacific Journal of Reproduction. 2016 Sep 1;5(5):365-70.
  6. Raposo MI, Cardoso M, Ormonde M, Stokreef S, Correia L, Pereira A. Obstetric management of delayed-interval delivery. Case reports in women's health. 2017 Oct 1;16:11-3.
  7. Christian LM, Ramilo O, Smith B, Mejias A, Carroll JE. African American women with subsequent preterm versus term delivery exhibit enhanced prenatal proinflammatory gene expression. Brain, Behavior, and Immunity. 2017 Nov 1;66:e10.
  8. Ray JG, De Souza LR, Park AL, Connelly PW, Bujold E, Berger H. Preeclampsia and preterm birth associated with visceral adiposity in early pregnancy. Journal of Obstetrics and Gynaecology Canada. 2017 Feb 1;39(2):78-81.
  9. Pisoni C, Garofoli F, Tzialla C, Orcesi S, Spinillo A, Politi P, Balottin U, Tinelli C, Stronati M. Complexity of parental prenatal attachment during pregnancy at risk for preterm delivery. The Journal of Maternal-Fetal & Neonatal Medicine. 2016 Mar 3;29(5):771-6.
  10. Wood SL, Tang S, Crawford S. Cesarean delivery in the second stage of labor and the risk of subsequent premature birth. American journal of obstetrics and gynecology. 2017 Jul 1;217(1):63-e1.
  11. Koucký M, Malíčková K, Kopřivová H, Cindrová‐Davies T, Hrbáčková H, Černý A, Šimják P, Pařízek A, Zima T. Low maternal serum concentrations of mannose‐binding lectin are associated with the risk of shorter duration of pregnancy and lower birthweight. Scandinavian journal of immunology. 2018 Jul;88(1):e12675.
  12. Calkavur S, Erdemir G, Onay H et al. Mannose-binding lectin may affect pregnancy outcome. Turk J Pediatr 2015;57:26-33.
  13. Minchinton RM, Dean MM, Clark TR, Heatley S, Mullighan CG. Analysis of the relationship between mannose-binding lectin (MBL) genotype, MBL levels and function in an Australian blood donor population. Scand J Immunol 2002;56:630-41.
  14. Arck PC, Hecher K. Fetomaternal immune cross-talk and its consequences for maternal and offspring's health. Nature Medicine 2013;19:548-56.
  15. Zhao AM, Xu HJ, Kang XM, Zhao AM, Lu LM. New insights into myeloid-derived suppressor cells and their roles in feto-maternal immune cross-talk. Journal of Reproductive Immunology. 2016;113:35-41.
  16. Wang LK, Huang MC, Liu CC, Chen CP. Second-trimester plasma mannose-binding lectin levels and risk of preterm birth. J Matern Fetal Neonatal Med 2017;30:678-83.
  17. Thevenon AD, Leke RG, Suguitan AL, Jr., Zhou JA, Taylor DW. Genetic polymorphisms of mannose-binding lectin do not influence placental malaria but are associated with preterm deliveries. Infect Immun 2009;77:1483-91.
  18. Catov JM, Scifres CM, Caritis SN, Bertolet M, Larkin J, Parks WT. Neonatal outcomes following preterm birth classified according to placental features. American Journal of Obstetrics and Gynecology 2017;216:411 e1- e14.
  19. Aagaard K, Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J. The placenta harbors a unique microbiome. Sci Transl Med 2014;6:237ra65.
  20. Stout MJ, Conlon B, Landeau M et al. Identification of intracellular bacteria in the basal plate of the human placenta in term and preterm gestations. American Journal of Obstetrics and Gynecology. 2013;208:226 e1-7.
  21. Kindinger LM, Bennett PR, Lee YS et al. The interaction between vaginal microbiota, cervical length, and vaginal progesterone treatment for preterm birth risk. Microbiome 2017;5:6.
  22. Pitiphat W, Gillman MW, Joshipura KJ, Williams PL, Douglass CW, Rich-Edwards JW. Plasma C-reactive protein in early pregnancy and preterm delivery. American journal of epidemiology. 2005 Oct 19;162(11):1108-13.
  23. Ghezzi F, Franchi M, Raio L, et al. Elevated amniotic fluid C-reactive protein at the time of genetic amniocentesis is a marker for preterm delivery. Am J Obstet Gynecol 2002;186:268–73.
  24. Roberts WL, Moulton L, Law TC, et al. Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin Chem 2001;47:418–25.